Three years later, the landmark Myriad decision on gene patents has led to some striking and unforeseen implications.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Mapping the Patent Landscape of Quantum Technologies: Patenting Trends, Innovation and Policy Implications
IIC - International Review of Intellectual Property and Competition Law Open Access 06 July 2022
-
Continental drift? Do European clinical genetic testing laboratories have a patent problem?
European Journal of Human Genetics Open Access 07 March 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Association for Molecular Pathology v. Myriad Genetics, Inc., 133 S. Ct. 2107 (2013).
Burk, D.L. J. Law Biosci. 2, 606–626 (2015).
In re BRCA1- & BRCA2- Based Hereditary Cancer Test Patent Litig v. Ambry Genetics Corp., 774 F.3d 755 (Fed. Cir. 2014).
Sherkow, J.S. & Greely, H.T. Annu. Rev. Genet. 49, 161–182 (2015).
Guerrini, C.J., Majumder, M.A. & McGuire, A.L. Nat. Biotechnol. 34, 145–147 (2016).
Graff, G.D. et al. Nat. Biotechnol. 31, 404–410 (2013).
Gordon, J. Cold Spring Harb. Perspect. Med. 5, http://dx.doi.org/10.1101/cshperspect.a020917 (2014).
Cook-Deegan, R. & Niehaus, A. Curr. Genet. Med. Rep. 2, 223–241 (2014).
Woessner, W.D. & Chadwick, R.A. Pharm. Pat. Anal. 2, 165–167 (2013).
Ratner, M. Nat. Biotechnol. 31, 663–665 (2013).
Gold, R.E., Cook-Deegan, R. & Bubela, T. Sci. Transl. Med. 5, 192ed9 (2013).
Offit, K. et al. J. Clin. Oncol. 31, 2743–2748 (2013).
Bubela, T. et al. Nat. Biotechnol. 31, 202–206 (2013).
Cook-Deegan, R. & Heaney, C. Annu. Rev. Genomics Hum. Genet. 11, 383–425 (2010).
Hopkins, M.M., Mahdi, S., Patel, P. & Thomas, S.M. Nat. Biotechnol. 25, 185–187 (2007).
35 USC § 101.
35 USC § 102.
35 USC § 103.
Mayo Collaborative Services v. Prometheus Laboratories, Inc., 132 S. Ct. 1289 (2012).
Alice Corporation v. CLS Bank International, 132 S. Ct. 2347 (2014).
Arora, A., Fosfuri, A. & Gambardella, A. Markets for Technology (MIT Press, 2001).
Sichelman, T. & Graham, S.J. Mich. Telecomm. & Tech. L. Rev. 17, 111–180 (2010).
Royzman, I. Nat. Biotechnol. 33, 925–926 (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Figures
Supplementary Figures 1–4 (PDF 344 kb)
Supplementary Table 1
Key Empirical Research on DNA-related patent protection (PDF 146 kb)
Rights and permissions
About this article
Cite this article
Aboy, M., Liddell, K., Liddicoat, J. et al. Myriad's impact on gene patents. Nat Biotechnol 34, 1119–1123 (2016). https://doi.org/10.1038/nbt.3719
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3719
This article is cited by
-
Mapping the patent landscape of medical machine learning
Nature Biotechnology (2023)
-
European patent protection for medical uses of known products and drug repurposing
Nature Biotechnology (2022)
-
Mapping the Patent Landscape of Quantum Technologies: Patenting Trends, Innovation and Policy Implications
IIC - International Review of Intellectual Property and Competition Law (2022)
-
Mapping the European patent landscape for medical uses of known products
Nature Biotechnology (2021)
-
One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?
Nature Biotechnology (2020)